1. Home
  2. CSTL vs MCFT Comparison

CSTL vs MCFT Comparison

Compare CSTL & MCFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$28.00

Market Cap

722.8M

Sector

Health Care

ML Signal

HOLD

Logo MasterCraft Boat Holdings Inc.

MCFT

MasterCraft Boat Holdings Inc.

HOLD

Current Price

$23.92

Market Cap

597.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSTL
MCFT
Founded
2007
1968
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Marine Transportation
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
722.8M
597.3M
IPO Year
2019
2015

Fundamental Metrics

Financial Performance
Metric
CSTL
MCFT
Price
$28.00
$23.92
Analyst Decision
Strong Buy
Hold
Analyst Count
6
5
Target Price
$45.50
$24.25
AVG Volume (30 Days)
290.0K
112.0K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.33
Revenue
$344,229,000.00
$284,203,000.00
Revenue This Year
$2.42
$9.18
Revenue Next Year
$12.69
$8.23
P/E Ratio
N/A
$74.82
Revenue Growth
3.66
N/A
52 Week Low
$14.59
$17.19
52 Week High
$44.28
$28.44

Technical Indicators

Market Signals
Indicator
CSTL
MCFT
Relative Strength Index (RSI) 75.45 46.01
Support Level $22.67 $23.21
Resistance Level $34.97 $24.09
Average True Range (ATR) 1.31 0.90
MACD 0.33 -0.07
Stochastic Oscillator 84.88 19.40

Price Performance

Historical Comparison
CSTL
MCFT

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. The company derives revenues through the delivery of test reports for its molecular diagnostic tests.

About MCFT MasterCraft Boat Holdings Inc.

MasterCraft Boat Holdings Inc designs, manufactures, and markets performance sport boats and outboard boats. The company is based in the United States and operates in three brand-specific segments. The MasterCraft segment generates the majority of the company's revenue and includes inboard boats for water skiing, wakeboarding, and wake surfing. The Pontoon segment produces pontoon boats at its Owosso, Michigan facility. Pontoon boats are used for general recreational boating. The Aviara segment produces luxury day boats at its Merritt Island, Florida facility. Aviara boats are used for general recreational boating.

Share on Social Networks: